Working closely with healthcare providers, including registered dietitians , is indispensable
Tirzepatide was initially approved as Mounjaro for type 2 diabetes management in 2022, and the same active ingredient is now marketed as Zepbound specifically for weight management
PlexusDx enrolls patients with HSA and FSA benefits, and requires no membership fees or insurance approval
My face has never looked so smooth Lauren is so dedicated to seeing her clients succeed with their goals, she is very professional, knowledgeable, and willing to assist with whatever your needs may be
Additional Phase 3 trials are still underway, including TRIUMPH-2 (evaluating retatrutide in adults with obesity and type 2 diabetes) and TRIUMPH-3 (evaluating cardiovascular outcomes), with results expected later in 2026